Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19
Clinical trial NCT04528667 · COMPLETED
Trial details
- NCT number
- NCT04528667
- Sponsor
- Sorrento Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-06
- Primary completion
- 2021-08-23
- Enrollment
- 396
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.